US pathology services are under sustained operational pressure. Diagnostic backlogs have grown considerably since 2020, and the ongoing consolidation of laboratory services into large regional networks has forced clinic managers and IT leads to confront a question that can no longer be deferred:
How well does your pathology lab reporting software integration actually connect to everything else?
When a laboratory information system cannot communicate with a clinic's electronic patient record, results get transcribed manually, turnaround times extend, and the risk of error increases at every handoff point. It affects the daily workflow of thousands of clinicians across health systems and private practices alike, impacting patient safety and operational efficiency.
This guide is written for healthcare administrators, practice managers, and IT leads who need a clear, practical account of pathology lab reporting software integration in the US context. It covers what integration actually means at the technical level, which standards govern it within the modern healthcare framework, what features to evaluate when selecting pathology lab software, and how to address the legacy system challenges that derail many projects.
What is Pathology Lab Reporting Software Integration?
The term "pathology lab software" covers a broad range of tools, and conflating them is a common source of confusion during procurement. It helps to draw a clear distinction between two separate layers of functionality that support the modern diagnostic workflow.
A Laboratory Information System (LIS), often referred to as a LIMS, is the operational core of a diagnostic laboratory. It manages internal lab workflow from the point a specimen is received: specimen tracking; processing queues; result verification by the pathologist; and final sign-off.
A full LIMS is typically deployed by large hospital hub laboratories or specialist centres handling high volumes of histology, cytology, and anatomic pathology work. Platforms such as Clinisys and Roche Navify operate at this level, managing complex data management tasks across entire laboratory networks with sophisticated automation capabilities.
What most clinics and private practices actually need is distinct from a full LIMS. They need the reporting and integration layer: the connectivity that pulls verified results out of the laboratory system and delivers them directly into the clinic's Electronic Health Record (EHR) or Practice Management System (PMS).
This is pathology lab reporting software integration in the practical sense. It is about getting the right structured data into the right clinical system, at the right time, without manual intervention, enabling true interoperability across the diagnostic pathway.
Understanding this distinction is the starting point for any procurement conversation. For a deeper overview of the software landscape, the guide to medical lab management software covers the leading solutions in detail.
Why Does Your Clinic Need This Integration?
The US healthcare system has been actively restructuring laboratory services around large reference laboratory networks and integrated delivery networks, consolidating previously independent hospital laboratories into collaborative networks. This shift has significant implications for data management and connectivity. A single patient episode may now involve specimen processing at one reference hub, specialist anatomic pathology review at another, and result delivery back to an independent physician's office or outpatient clinic that sits outside the network entirely.
This architecture makes integration a strategic requirement. Without robust connectivity between systems, the network model creates more data silos. A result verified in a Clinisys environment at a network hub must travel accurately and completely into the EHR used by the referring clinician.
Platforms like Roche Navify are increasingly used to aggregate diagnostic data across multiple laboratory sources, but that aggregation only delivers clinical value when it connects outward to the systems clinicians actually use.
The Office of the National Coordinator for Health Information Technology (ONC) has set clear expectations around interoperability as part of the broader digital transformation agenda. Organisations operating within US federal frameworks are expected to adopt standards that allow systems to communicate without custom one-off interfaces that are expensive to build and brittle to maintain. Network consolidation requires a data infrastructure that is scalable, standards-compliant, and capable of presenting a unified view of results to any authorised clinician, regardless of which system they are working in.
For private clinics operating outside large hospital systems, the same logic applies. Patients move between different care settings, and their diagnostic data needs to move with them.
EHR interoperability solutions that support open standards are increasingly the baseline expectation, not a premium differentiator. Multi-disciplinary team collaboration depends on seamless data sharing.
Technical Standards for Pathology Lab Software
The technical foundation of pathology lab reporting software integration in the US rests on a small number of critical standards. Understanding them is essential for evaluating whether a proposed solution will actually work within your environment and support regulatory compliance.
- HL7 FHIR (Fast Healthcare Interoperability Resources) is the current gold standard for modern healthcare data exchange. HL7 FHIR messaging enables systems to exchange structured clinical data through defined API calls, rather than relying on proprietary file formats or manual exports.
For pathology reporting, this means a lab result can be transmitted as a structured FHIR resource that includes not just the numeric value, but the reference range, the requesting clinician, the specimen type, and a timestamp, all in a format that the receiving EHR can parse and display automatically.
- SNOMED CT and LOINC are the clinical terminology standards mandated by US health authorities for semantic interoperability. They ensure that a test result described as "biopsy of lesion of skin" in one system is understood as exactly the same concept in another, regardless of how different vendors have labelled it internally.
Without proper terminology alignment, two systems may exchange data successfully at the technical level while still producing results that are ambiguous or misread at the clinical level. This is a particularly important consideration for anatomic pathology reporting, where precision in terminology directly affects clinical decisions.
- Older legacy systems present a real compliance challenge here. Many EHRs (Electronic Health Records) deployed in US hospitals were built before HL7 FHIR became the standard, and retrofitting them to support modern API connectivity is complex and resource-intensive. A bi-directional interface built on modern standards can bridge this gap without requiring a full system replacement.
| Standard | Purpose | Clinical Relevance |
|---|---|---|
| HL7 FHIR | Structured data exchange via API | Enables automatic result delivery into EHR/PMS |
| SNOMED CT / LOINC | Clinical terminology consistency | Ensures test descriptions are semantically identical across systems |
| Direct / Secure Transport | US secure messaging transport | Carries HL7 messages securely across network boundaries |
Key Pathology Lab Software Integration Features to Look For
When evaluating pathology lab software for integration purposes, the feature list matters less than the architecture behind it. Many systems offer PDF result delivery, which is better than a fax but remains a form of manual transcription in disguise. A clinician still has to read the PDF, interpret the values, and enter relevant data into the patient record by hand.
Genuine pathology lab reporting software integration requires the following capabilities:
- Bi-directional order communications. The system should support bi-directional data flow: outbound test requests from the clinic to the lab, and inbound structured results back to the EHR. This closes the loop on the entire diagnostic workflow and enables specimen tracking from request to result delivery.
- Structured results delivery and reporting. Results should arrive as discrete, queryable data fields, not as embedded document images. This enables automated alerting for critical values, graphical trending over time, and accurate reporting across patient populations. Synoptic reporting capabilities ensure standardised output formats.
- Digital pathology image import. For specialist referrals involving histology or cytology, the ability to import digital pathology images directly into the patient record is increasingly valuable. Rather than requiring a separate image management system, this feature brings visual diagnostic data into the same clinical workspace as the text results.
- Middleware and order comms standards compliance. The integration layer should support established order comms protocols, whether that is HL7 v2 messaging for legacy environments or FHIR-based APIs for modern systems. A middleware approach allows a clinic to connect to multiple laboratory systems simultaneously without bespoke development for each.
- Barcoding and specimen tracking. Printing barcoded sample labels directly from the PMS at the point of request reduces the risk of specimen identification errors and creates an auditable chain of custody from collection to reporting.
![[en] lab orders](/i/2ctud73oU6cbpfIn5qDknU/13cedd418d16ba8d1ab6b093cedccfc9/order___orders.png?w=700)
To see how these capabilities work in practice, the Medesk lab Integration page outlines how the platform handles lab requests and results within a single unified workflow.
Customisable Reporting Features
Beyond basic structured data delivery, modern laboratories require highly flexible and customisable reporting capabilities. Pathology groups serve demanding referring physicians who often require reports formatted to specific clinical preferences. Robust reporting software allows labs to build custom templates that prioritise key diagnostic data, incorporate detailed anatomic diagrams, and highlight critical values. The ability to export these structured reports into various formats, such as PDF, CSV, or directly into a referring physician's EHR via FHIR, is essential for maintaining clinical efficiency and meeting diverse client expectations.
End-to-End Specimen Tracking and Chain of Custody
Dedicated specimen tracking software addresses one of the most consequential pre-analytical failure points in laboratory medicine: specimen misidentification and handling errors that occur before any analysis takes place. A barcode printed at the point of collection links every subsequent step, from transport to accessioning to processing and final reporting, to a single unambiguous patient record. This end-to-end chain of custody is not merely an operational convenience. It is a quality management requirement that supports CLIA compliance and provides defensible documentation in the event of a discrepancy or adverse event.
On the clinic side, integrated specimen tracking connects the ordering PMS to the receiving LIS so that status updates travel back to the requesting clinician automatically. A clinician can see that a specimen has been received, is in process, or has been reported without placing a phone call. This visibility reduces unnecessary repeat collections and prevents delays caused by specimens that were logged in the lab but not acknowledged in the clinic's system.
Benefits of an Integrated Pathology Workflow
The business case for integration is built on efficiency, but the clinical case is built on patient safety. Both are relevant to the decision.
On the efficiency side, reducing manual data entry is the most direct source of time-saving. When results arrive automatically into the patient record, the administrative task of transcription disappears. Practices consistently report reductions in clerical workload once bi-directional interfaces replace manual result entry, freeing staff to focus on patient-facing tasks.
Turnaround time improves for two reasons:
- First, there is no delay between a result being verified at the lab and it appearing in the clinician's workflow.
- Second, automation of result routing ensures that urgent results reach the right person immediately, without depending on a phone call or a manually checked inbox.
For a multi-disciplinary team managing complex cases, this speed advantage has direct clinical value.
On the patient safety side, the reduction in transcription errors is the most significant benefit. Manual data entry introduces the risk of transposed digits, wrong patient association, and missed critical values. Automated integration eliminates these failure points by removing the human step from the data transfer entirely. An audit trail of every data exchange also supports regulatory compliance and provides evidence in the event of a clinical incident.
On the financial side, fewer errors mean fewer adverse events to investigate and remediate. Lower administrative burden reduces staffing costs. Faster turnaround time shortens diagnostic delays that consume clinical resource and extend patient journeys. Laboratories that have moved to fully integrated workflows report meaningful improvements in both volume capacity and revenue recovery, driven by more accurate and timely charge capture rather than by integration alone.
Laboratory Billing and Revenue Cycle Integration
Integrating diagnostic data with financial systems is critical for maintaining a healthy practice. Effective laboratory revenue cycle management (RCM) relies on automated coding and claim scrubbing features built directly into the integration pathway. When pathology results are verified, the system should automatically trigger the appropriate CPT and ICD-10 codes, passing them seamlessly into your billing workflow. This automation reduces manual coding errors, dramatically lowers the rate of claim denials, and accelerates reimbursement cycles for the clinic or laboratory.
| Integration Benefit | Mechanism | Clinical or Operational Impact |
|---|---|---|
| Reduced turnaround time | Automated result delivery, no manual routing | Faster clinical decisions, shorter diagnostic delays |
| Fewer transcription errors | Structured data transfer, no manual entry | Improved patient safety, lower risk of adverse events |
| Lower administrative cost | Staff freed from manual result logging | Reallocation of resource to patient-facing tasks |
| Improved audit trail | Automated timestamped data exchange | Supports regulatory compliance and clinical governance |
Laboratory Billing and Revenue Cycle Management Integration
Revenue cycle management for pathology laboratories operates differently from general practice billing. The diagnostic workflow generates billable events at multiple points: specimen accessioning, pathologist professional interpretation, technical component processing, and any ancillary stains or molecular tests ordered during the case. Each of these must be captured accurately in the integration layer and translated into the correct billing codes before a claim is submitted. When this charge capture process depends on manual reconciliation between the LIS and the billing platform, errors accumulate and revenue is lost.
An integrated billing workflow addresses this by connecting result verification directly to charge generation. When a pathologist signs out a case, the integration layer reads the diagnostic codes, the procedure codes, and the specimen count from the verified report and passes them automatically to the practice management or billing system. This removes the manual step of re-keying case data into the billing platform and eliminates a major source of coding discrepancies.
Claim denial management also improves significantly in an integrated environment. When a claim is rejected, the integration layer can surface the denial reason alongside the original case record, allowing billing staff to identify the root cause quickly. Common denial triggers in pathology, such as missing prior authorisation, incorrect specimen coding, or duplicate bill flags, are easier to resolve when the billing team has direct visibility into the original order and result data.
For independent laboratories and private pathology practices, the connection between the LIS and the billing system is often the single highest-value integration to prioritise. It directly affects cash flow, reduces days in accounts receivable, and gives practice leadership accurate data on which payers and test types drive the most revenue. Practices evaluating platforms should ask vendors specifically how charge capture is triggered, what coding logic is applied at sign-out, and how the system handles split-bill scenarios where the technical and professional components are billed separately.
The Most Common Integration Challenges in Legacy Systems
The most common practical obstacle to pathology lab reporting software integration is the presence of legacy systems on one or both ends of the interface. Many hospitals still operate legacy EHR platforms that predate modern API standards. Private clinics may be running older practice management systems that were not designed with interoperability in mind. Replacing these systems entirely is often neither practical nor cost-effective in the short term.
Cloud-based middleware addresses this challenge by acting as a translation layer between old and new systems. Rather than requiring a legacy LIMS to support modern FHIR APIs natively, a middleware platform can receive data in the format the legacy system produces and transform it into the structured format the receiving EHR expects. This preserves existing infrastructure investment while still enabling the data management benefits of a connected workflow.
Data migration is a related concern. When a clinic transitions to a new PMS or integration layer, historical result data needs to move with it. Careful planning of the migration process is essential to maintain continuity of the patient record.
The article on data continuity in practice management software transition covers the key considerations for managing this transition without disrupting clinical operations.
As healthcare systems spread across more locations, the network behind them matters just as much as the software they run. Large lab networks rely on stable IP address resources to keep data moving smoothly between systems. With IPv4 becoming harder to access, many organizations look for flexible ways to manage and scale their IP address space so connections stay reliable across different sites.
Technical support during and after implementation is also a critical selection criterion. Integration projects frequently encounter configuration issues that require specialist knowledge of both the clinical system and the laboratory platform. A vendor with direct experience of complex US health system integrations will be able to resolve these issues more quickly than one that has only worked in other markets.
Cloud vs. On-Premises Deployment Models
When selecting a laboratory integration solution, administrators must choose between on-premises servers and cloud-hosted environments. Modern clinics are increasingly prioritising cloud-based pathology software to avoid the heavy IT burden of on-site server maintenance, operating system updates, and physical security management. Cloud deployment offers scalable architecture, automatic software updates, and secure remote access for distributed physician networks, making it the preferred and most cost-effective model for growing practices.
AI, Telepathology and Digital Pathology Integration
The direction of travel in diagnostic technology is clear. Artificial intelligence is increasingly being applied to diagnostic imaging tasks that were previously the exclusive domain of the pathologist, including the analysis of whole slide imaging from histology and cytology preparations. Advanced algorithms can now highlight areas of concern on digital slides, helping pathologists prioritise critical cases and reduce diagnostic variability.
Machine learning models trained on large image datasets can flag abnormalities, prioritise urgent slides, and provide quantitative measurements that support clinical decision-making.
Digital pathology, the practice of digitising glass slides into high-resolution whole slide images for remote review and AI-assisted analysis, is moving from research settings into routine clinical use. Telepathology, where a pathologist reviews cases remotely via a digital platform, is already operational in several large health systems and is accelerating as a response to workforce pressures.
Whole-slide imaging (WSI) is the technical foundation that makes both AI-assisted triage and remote sign-out possible. A WSI scanner digitises an entire glass slide at diagnostic resolution, producing an image file that can be transmitted, stored, and reviewed on any authorised workstation without physical handling of the original slide. For telepathology workflows, this means a pathologist can sign out cases from a remote location with the same information available at a traditional microscope. For AI applications, the digital slide becomes the input to computational analysis pipelines that can flag suspicious regions, quantify biomarker expression, or prioritise urgent cases within a worklist.
The transition from glass slides to digital pathology is a significant implementation undertaking. Laboratories considering this shift should evaluate several practical questions before committing to a platform. First, does the WSI scanner vendor's output format integrate cleanly with the LIS and reporting platform, or does it require a proprietary viewer? Second, how will existing glass slide archives be handled during the transition period when both physical and digital workflows may run in parallel? Third, what network infrastructure is required to move large image files between acquisition hardware, storage systems, and remote review workstations reliably? Fourth, what AI capabilities does the platform include natively, and how are algorithm outputs surfaced within the pathologist's sign-out workflow rather than as a separate application?
AI-native platforms such as Proscia Concentriq are purpose-built to address these integration questions, positioning computational pathology tools alongside traditional reporting rather than as a bolt-on. More established LIS platforms are increasingly adding digital pathology modules, but the depth of AI integration varies considerably across vendors. For clinics and laboratories evaluating this transition, the key criterion is whether the AI output is embedded in the diagnostic workflow or requires the pathologist to consult a separate interface, as the latter limits adoption in routine practice.
For integration planning purposes, the shift to digital pathology means that pathology lab software must increasingly handle not just structured text results, but large image files, AI-generated annotations, and metadata from image analysis workflows. A system built on open standards with a robust API architecture is well placed to accommodate these data types as they become a standard part of the diagnostic workflow.
Regulatory Compliance: Meeting CLIA, CAP, and HIPAA Standards
Adhering to strict regulatory requirements is non-negotiable for US medical facilities. Implementing robust CLIA compliance software ensures that laboratories meet federal standards for quality testing, result accuracy, and operational documentation.
CLIA proficiency testing documentation is one of the most audit-sensitive areas of laboratory compliance. Laboratories must demonstrate participation in approved proficiency testing programmes for every regulated analyte they report, and they must retain documentation of proficiency testing results and corrective actions. An integrated LIS or reporting platform that captures this documentation systematically reduces the administrative burden of preparing for a CLIA survey and provides auditors with the structured evidence they need quickly.
CAP accreditation introduces an additional layer of quality management requirements on top of CLIA. The College of American Pathologists publishes laboratory checklists covering hundreds of inspection criteria across specimen handling, result reporting, quality control, and personnel qualifications. Software that is designed with CAP checklist alignment in mind supports laboratories in maintaining continuous inspection readiness rather than preparing reactively before each accreditation cycle.
Synoptic reporting plays a direct role in CAP protocol compliance. CAP has published standardised cancer protocols that define the required data elements for reporting resected tumours across dozens of diagnostic categories. Synoptic reporting tools that enforce these required elements at the time of sign-out ensure that reports are complete and structured consistently, reducing the risk of a deficiency finding during a CAP inspection.
Audit trails are a compliance requirement that spans both CLIA and CAP frameworks, as well as HIPAA data protection obligations. A comprehensive audit trail logs every action taken on a patient record or result, including who accessed it, when, and what change was made. During a CAP inspection or a HIPAA compliance review, the ability to produce a complete and accurate audit trail is evidence of a functioning quality management system. Platforms that embed audit trail functionality into the core data architecture, rather than treating it as an add-on reporting feature, provide stronger compliance support.
Furthermore, deploying lab software with strong data-protection standards helps keep Protected Health Information (PHI) secure and encrypted during transit between the laboratory, the integration engine, and the clinic.
Leading Pathology Lab Reporting Software Solutions to Evaluate
Selecting the right platform depends on specialty focus, EHR connectivity requirements, deployment preferences, and the scale of the laboratory. The following solutions represent the range of options most commonly evaluated by pathology groups and independent laboratories in the US market.
NovoPath 360 is a full anatomic pathology LIS with strong EHR interoperability credentials. It covers histology, cytology, molecular pathology, and hematopathology within a single platform and includes a dedicated Discrepancy Module for structured quality review. NovoPath is positioned for independent pathology groups and hospital-affiliated labs that need deep specialty coverage alongside prebuilt interface libraries for common EHR environments.
Lumea (formerly elea) is an AI-native digital pathology platform oriented toward computational pathology workflows. It is designed for laboratories moving toward whole-slide imaging as their primary review medium and integrates AI-assisted analysis into the sign-out workflow rather than as a parallel tool.
Proscia Concentriq takes a similar approach, positioning itself as a digital and computational pathology platform built around the whole-slide image as the central data object. Its integration architecture is designed to connect with existing LIS environments rather than replace them, making it a relevant option for laboratories that want to add AI and digital capabilities without migrating their core reporting system.
Epic Beaker is the pathology and lab module within the Epic EHR ecosystem. For health systems already running Epic across their clinical operations, Beaker provides deep native integration between the laboratory and the rest of the patient record. It is less commonly deployed as a standalone laboratory platform outside Epic-primary organisations, but within those environments it eliminates many of the interface challenges that arise when a separate LIS must communicate with a separate EHR.
Clinisys PowerPath (formerly CoPathPlus) is one of the most widely deployed anatomic pathology LIS platforms in the US market, with a particularly strong presence in large hospital and academic medical centre environments. It supports complex multi-site laboratory networks and has an established ecosystem of interface partnerships with major EHR vendors.
Each of these platforms addresses a different combination of specialty, scale, and technology maturity. The right starting point is defining which of these dimensions matters most for your laboratory before entering vendor evaluations.
How to Choose the Right Pathology Lab Reporting Software Integration Partner
Pathology lab reporting software integration is an ongoing strategic commitment to maintaining connected, accurate, and secure diagnostic data flows across a clinical network. The right integration partner supports secure health information exchange, communicates using HL7 FHIR messaging, handles the complexity of legacy system connectivity, and scales as your organisation grows.
Medesk is built to meet these requirements. With support for structured lab result delivery, direct API connectivity to laboratory systems, and compliance with international interoperability standards, Medesk provides the integration layer that connects your clinic's diagnostic workflow to the broader healthcare ecosystem.
Whether you are managing a single private practice or coordinating across multiple sites, Medesk keeps result data accurate, accessible, and properly governed within a single practice management software platform.
If you are ready to replace manual result handling with a connected, automated pathology workflow, explore what Medesk can do for your practice today. Start a free version and transform diagnostic efficiency and patient safety.
Evaluating Vendors: Questions to Ask Before You Buy
The decision to invest in a new pathology lab reporting software integration platform is not resolved by a feature checklist alone. The demo environment rarely reflects the complexity of a live implementation, and vendors that perform well in a structured presentation may struggle when confronted with the specific configuration of your existing systems. A structured set of questions asked before you buy will surface gaps that a standard product tour does not reveal.
On HL7 FHIR compliance: Ask the vendor to demonstrate a live FHIR API call rather than a slide describing FHIR support. Ask specifically which FHIR resource types are supported for laboratory orders and results, and whether the implementation has been tested against the EHR or PMS you are currently running. A vendor that cannot answer this concretely is unlikely to have the integration depth the specification implies.
On EHR compatibility: Ask for a reference list of existing integrations with your EHR vendor's platform, and ask to speak with a current customer running that specific interface. Prebuilt interface libraries reduce implementation time significantly, but the quality of a prebuilt interface varies. Asking for a reference customer in your EHR environment is the most reliable way to verify this.
On scalability: Ask how the platform performs when result volume increases by an order of magnitude, either through practice growth or through the addition of a new reference lab relationship. Ask whether pricing scales with volume, and what the architecture looks like for multi-site deployments where different sites may use different EHR systems.
On specialty fit: Ask whether the platform has been deployed in laboratories with your specific case mix, whether that is dermatopathology, cytology, molecular pathology, or another subspecialty. Reporting templates, coding logic, and synoptic reporting requirements differ substantially across specialties, and a platform optimised for clinical pathology may not serve an anatomic pathology group well without significant configuration work.
Red flags to watch for: Be cautious of vendors who describe HL7 FHIR support only in terms of inbound data they can receive, without demonstrating outbound structured result delivery. Be cautious of implementation timelines that do not include a parallel-run period where both old and new systems operate simultaneously. Be cautious of reference customers who are all running the same EHR in similar-sized practices, as this may indicate limited adaptability outside a narrow deployment scenario.
Frequently Asked Questions About Pathology Lab Integration
- What is the difference between a LIS system and pathology reporting software?
LIS or LIMS manages the internal operational workflow of the laboratory itself, including specimen tracking, processing, quality control, and pathologist sign-off. Pathology reporting software integration, by contrast, focuses on the outbound delivery of those verified results into the clinic's EHR or PMS.
- How does integration improve patient safety?
Every time a result is manually re-entered from one system to another, there is an opportunity for error: transposed values, incorrect patient matching, or delayed entry. Automated integration removes these handoff points. It also enables real-time alerting for critical results.
- What are the key features to look for in pathology lab software integration?
The most important features are bi-directional data flow, support for HL7 and FHIR standards, digital pathology image import capability, barcoding and specimen tracking from the point of request, and compliance with US standards, including secure transport and SNOMED CT terminology.
- How long does it take to implement a lab integration project?
Implementation timelines vary depending on the complexity of the laboratory system and the specific infrastructure of the clinic. However, a straightforward cloud-based middleware integration can often be established within four to six weeks, whereas connecting to highly customised legacy systems may take several months to fully deploy and test.
- What is the best pathology lab reporting software for a private practice or independent lab?
There is no single answer because the right platform depends on several intersecting factors: specialty focus (anatomic pathology, cytology, molecular, or a mix), the EHR or practice management system already in use and the depth of interface available for it, whether cloud-based or on-premises deployment fits the organisation's IT environment and data governance requirements, and whether the laboratory holds or is seeking CLIA certification and CAP accreditation, since those compliance requirements affect which reporting and quality management features are non-negotiable. Evaluating vendors against these four criteria, rather than against a generic feature list, will narrow the field to platforms that are genuinely suited to your operating context.
- Is there a pathology lab app available for mobile access?
Modern cloud-based LIS and pathology reporting platforms typically provide web-responsive interfaces that function on mobile browsers, allowing pathologists and clinicians to review results and sign out cases from a tablet or smartphone without a dedicated application. Some vendors also offer dedicated iOS or Android applications for pathologist sign-out and critical result review, with push notifications for urgent cases. Others rely entirely on a responsive web portal rather than a native app. When evaluating platforms for mobile access, ask specifically whether the mobile interface supports full sign-out functionality or only read access, as the distinction matters for remote and on-call workflows.
